The invisible hand: How epigenetics shapes CAR T cell destiny

Mol Ther. 2024 Jun 5;32(6):1614-1616. doi: 10.1016/j.ymthe.2024.05.007. Epub 2024 May 17.

Authors

Alaa Ali¹, Yi Zhang², John DiPersio³

Affiliations

¹ Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA. Electronic address: alaa.ali@gunet.georgetown.edu.
² Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA; Center for Discovery and Innovation, Nutley, NJ, USA.
³ Washington University in Saint Louis, Saint Louis, MO, USA.

PMID: 38761798
PMCID: PMC11184405 (available on 2025-06-05)
DOI: 10.1016/j.ymthe.2024.05.007

No abstract available

Publication types

Editorial

MeSH terms

Epigenesis, Genetic*
Humans
Immunotherapy, Adoptive* / methods
Receptors, Chimeric Antigen* / genetics
Receptors, Chimeric Antigen* / immunology
Receptors, Chimeric Antigen* / metabolism
T-Lymphocytes* / immunology
T-Lymphocytes* / metabolism

Substances

Receptors, Chimeric Antigen